ISA Pharmaceuticals and Scancell enter collaboration agreement for the manufacturing, development and commercialisation of Modi-1 / AMPLIVANT® combination

-- AMPLIVANT-Modi-1 conjugate expected to enter clinic in H1 2019 -- Collaboration seeks to further leverage Moditope® platform

Share this post:

Recent Posts

Comments are closed.